BeOne Medicines (ONC) Free Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 66.37% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.98% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 137.65% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,092.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,092.51% |
| Dec 31, 2025 | -29.99% |
| Sep 30, 2025 | 646.46% |
| Jun 30, 2025 | 229.26% |
| Mar 31, 2025 | 95.29% |
| Dec 31, 2024 | 159.92% |
| Sep 30, 2024 | -10.74% |
| Jun 30, 2024 | 56.90% |
| Mar 31, 2024 | 46.16% |
| Dec 31, 2023 | -53.78% |
| Sep 30, 2023 | 109.14% |
| Jun 30, 2023 | -10.85% |
| Mar 31, 2023 | -122.86% |
| Dec 31, 2022 | -298.12% |
| Sep 30, 2022 | -19.16% |
| Jun 30, 2022 | 8.51% |
| Mar 31, 2022 | -399.07% |
| Dec 31, 2021 | 152.96% |
| Sep 30, 2021 | -61.62% |
| Jun 30, 2021 | -73.94% |
| Mar 31, 2021 | 125.91% |
| Dec 31, 2020 | -27.90% |
| Sep 30, 2020 | -34.79% |
| Jun 30, 2020 | -349.12% |
| Mar 31, 2020 | -87.55% |
| Dec 31, 2019 | -93.84% |
| Sep 30, 2019 | -50.89% |
| Jun 30, 2019 | 47.85% |
| Mar 31, 2019 | -69.71% |
| Dec 31, 2018 | -242.02% |
| Sep 30, 2018 | -1,331.51% |
| Jun 30, 2018 | -97.13% |
| Mar 31, 2018 | -201.19% |
| Dec 31, 2017 | 341.22% |
| Sep 30, 2017 | 24.48% |
| Jun 30, 2017 | -136.99% |
| Mar 31, 2017 | -63.82% |
| Dec 31, 2016 | -231.18% |
| Sep 30, 2016 | -34.96% |
| Jun 30, 2016 | -292.55% |
| Mar 31, 2016 | -233.34% |